| Literature DB >> 26555613 |
Jukka Pajarinen1, Tzu-Hua Lin1, Taishi Sato1, Florence Loi1, Zhenyu Yao1, Yrjö T Konttinen2, Stuart B Goodman1.
Abstract
Macrophages play a key role in tissue homeostasis as well as in a range of pathological conditions including atherosclerosis, cancer, and autoimmunity. Many aspects of their in vivo behavior are, however, poorly understood. Bioluminescence imaging (BLI) with green fluorescent protein (GFP) and firefly luciferase (FLUC) labelled autologous reporter macrophages could potentially offer a powerful tool to study macrophage biology, but this approach has been hindered by the relative difficulty of efficient gene transfer into primary macrophages. Here we describe a straightforward method for producing large numbers of GFP/FLUC expressing mouse primary macrophages utilizing lentivirus vector, cyclosporine, and a double infection strategy. Using this method we achieved up to 60% of macrophages to express GFP with correspondingly high FLUC signal. When injected into the circulation using a mouse model of local biomaterial induced inflammation and osteolysis, macrophages were initially detectable within the lungs, followed by systemic homing to the local area of chronic inflammation in the distal femur. In addition, transduced macrophages maintained their ability to assume M1 and M2 phenotypes although the GFP/FLUC expression was altered by the polarizing signals. These reporter macrophages could prove to be valuable tools to study the role of macrophages in health and disease.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26555613 PMCID: PMC4640705 DOI: 10.1371/journal.pone.0142736
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Reporter macrophage viability.
GFP and FLUC expressing reporter macrophages were produced by transducing mouse bone marrow macrophages with lentivirus vector in the presence of cyclosporine, DEAE-dextran or polybrene. The 24-hour virus infection was done either once or repeated after a 24-hour rest period (single vs. double infection). The percentage of viable cells was assessed three days after the second infection by flow cytometry and propidium iodide staining.
| Treatment group | Viability (%) | |
|---|---|---|
| Single infection | Double infection | |
| Cyclosporine | 96.6 | 96.3 |
| Dextran | 97.5 | 97.1 |
| Polybrene | 96.4 | 97.1 |